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The CIDI is a fully standardised diagnostic interview designed for assessing mental disorders based on 
the definitions and criteria of ICD-1Oand DSM-IlI-R. Field trials with the CIDI have been conducted 
in 18 centres around the world, to test the feasibility and reliability of the CIDI in different cultures 
and settings, as well as to test the inter-rater agreement for the different types of questions used. Of 
590 subjects interviewed across all sites and rated by an interviewer and observer, 575 were eligible 
for analysis. The CIDI was judged to be acceptable for most subjects and was appropriate for use in 
different kinds of settings. Many subjects fulfilled criteria for more than one diagnosis (lifetime and 
six-month). The most frequent lifetime disorders were generalised anxiety, major depression, tobacco 
use disorders, and agoraphobia. Percentage agreements for all diagnoses were above 90% and the 
kappa values were all highly significant. No significant numbers of diagnostic disconcordances were 
found with lifetime, six-month, and four-week time frames.    
 
 
 
The Composite International Diagnostic Interview (CIDI) has been produced in the 
framework of a major project (the Joint Project on Diagnosis and Classification of Mental 
Disorders, and Alcohol- and Drug-Related Problems) undertaken by the World Health 
Organization (WHO) and the US Alcohol, Drug Abuse and Mental Health Administration 
(ADAMHA). It is a comprehensive, fully standardised diagnostic interview for the assessment 
of mental disorders according to the definitions and criteria of ICD-10 (World Health 
Organization, 1989a), and DSM-III-R (American Psychiatric Association, 1987). The CIDI 
has been designed for use in a variety of cultures and settings. Although it is primarily 
intended for use in epidemiological studies of mental disorders, the CIDI can also be used for 
clinical and research purposes, and can be supplemented by modules for diagnoses not 
covered in the core version. In the course of development (Robins et al, 1988), the instrument 
was subjected to a number of tests for feasibility, diagnostic coverage, test-retest reliability as 
well as procedural reliability (Semler et al, 1987, 1988; Farmer et al, 1987; Semler, 1990; 
Wittchen et al, 1990).  
 
As part of the further development and test of the CIDI, this paper summarises the findings of 
the first major international WHO field trial of the ‘pre-final’ version of the CIDI. The study 
was initiated to explore the CIDI's cross-cultural acceptability and feasibility, and to 
determine its reliability in different settings and countries. Because several test-retest 
reliability studies of the CIDI approach have already been conducted (Burke, 1986; Semler et 
al, 1987, 1988; Wittchen et al, 1989) a complex inter-rater reliability design was chosen for 
the field trials, in order to allow for the identification of cross-cultural problems in the CIDI as 
well as to study reasons for disagreement between raters. The major objectives of the CIDI 
field trials were: (a) to report data on the feasibility of the CIDI in different cultures and 
settings, (b) to assess reliability between raters using the CIDI, (c) to report the CIDI's inter-
rater agreement for the different types of questions used in the CIDI, and (d) to evaluate 
possible reasons for discrepancies in rating between an interviewer and an observer.  
 
Method  
 
For the test of inter-rater reliability, each subject was examined by an interviewer/observer 
pair. The interviewer conducted the interview, while the observer independently - and without 
having access to the interviewer ratings - scored a separate booklet while sitting in the same 
room. While sitting by and making the CIDI codings, the observer additionally noted all the 
interviewer's mistakes and inconsistencies detected, by circling the respective items. Once the 
interviewer had finished the CIDI, the observer was then free to ask all these circled questions 
or even sections of the CIDI again, to verify that his/her original codings were correct. If 
necessary the observer then recoded the CIDI according to the second administration of the 
respective CIDI question or section. During this procedure the interviewer was not allowed to 
change any of his/her previous codings.  
 
The data from the resulting two CIDI booklets – the original CIDI codings of the interviewer 
and the final CIDI codings of the observer – were used to calculate the inter rater agreement. 
After the respondent had left the room, the interviewer and the observer reviewed all 
questions circled by the observer. Using the Discrepancy Resolution Sheet (DRS) (see 
below), all discrepancies between the codings of the observer and those of the interviewer 
were discussed to identify the reason for the discrepancy. Multiple ratings could be made for 
each of the discrepant CIDI items. The following classes of reasons for discrepancies were 
used: (a) mistakes in the presentation of a CIDI question, (b) mistakes in the additional 
‘probe’ questions for severity and exclusion criteria, (c) coding errors, (d) misunderstandings 
on either the interviewer's or the patient's side, (e) ambiguous questions and (f) changes in the 
respondent's answers to the same question. If possible, both the interviewer and the observer 
made final consensus ratings. These codings were then written down on the DRS. Only 
discrepancies in the codings of the CIDI symptom questions, thus no discrepancies for the so-
called ‘recency’ and ‘severity’ questions, were discussed.  
 
At the conclusion of each session the interviewer and the observer completed a simple 
interview report in order to document problems with the interview, including suggestions for 
resolving them. This report emphasised the identification of points of uncertainty, based on 
cultural factors, translation problems, or other problems in the interview schedule. Each 
interview was audiotaped, or if feasible videotaped, to enable the sources of discrepancies to 
be rated subsequently. In each centre, the editor or field supervisor reviewed three tapes per 
interviewer, at random, to check on the administration of the interview and to identify 
possible uncertainties with the study procedure.  
 
Participating centres and sampling of subjects  
 
Altogether 18 centres participated in the CIDI field trials. The trials were carried out in a 
variety of settings ranging from specialised psychiatric in-patient and out-patient units to 
general practice settings. At each a minimum of 25 (mostly 32) subjects were interviewed. 
The sampling process for patients differed slightly between centres depending on the size of 
the institution and the number of available interviewers (see below). All sites selected patients 
typically found in their settings. Exclusion criteria were: (a) evident severe cognitive 
impairment in language or communication, (b) no signed consent to the study procedure, 
which included video- or audiotaping, (c) age under 18 or over 65 years. Table 3 indicates the 
sites, the number of subjects selected, and classifies the sites into three groups – psychiatric 
in-patient setting, psychiatric out-patient setting, and other – characterises the type of 
institution. Some sites sampled a proportion of their subjects in an in-patient setting and 
another proportion in an out-patient or ‘other’ setting. Although at each site samples if 
possible were to be selected randomly, there were some inconsistencies in the selection 
process (see footnote to Table 3).  
 
CWI interviewers and training  
 
At each site, every interviewer completed at least four interviews as an interviewer and 
another four as observer, in alternate order. A random assignment was feasible at only six 
sites. The number of interviewers per site varied between three and eight.  
 
In addition an attempt was made to study potential differences between clinician and non-
clinician interviewers (Table 3). ‘Non-clinicians’ were defined as interviewers who were not 
able to make a diagnosis in the absence of a standardised interview (medical or psychology 
students, nurses and social workers working in the institution). ‘Clinicians’ were defined as 
mental health specialists, able to make diagnoses independently (psychiatrists or clinical 
psychologists). Altogether 108 interviewers (53 clinical, 55 non-clinical) participated in the 
study. Pairing of clinician and non-clinician interviewers and observers was randomised at 
five sites only, in order to allow for an analysis of differences. Eighty-seven patients were 
examined by clinician pairs, 49 by non-clinician pairs, and 454 by clinician-non clinician 
pairs.  
 
The CIDI requires for proper administration a minimum of five days' continuous training. The 
key investigators of all participating sites were trained centrally in a one-week training session 
using the CIDI manual, the standardised training package, as well as the item-by-item 
specifications available for the CIDI. These key trainers were then provided with the training 
materials to prepare their on-site training seminars according to the guidelines in this training 
package. Before commencing the study, each interviewer completed at least two CIDI 
interviews under the close supervision of the key investigator.  
 
Instruments  
 
Three instruments were used in this trial: the CIDI, the Evaluation Sheet (ES) and the 
Discrepancy Resolution Sheet (DRS).  
 
The CIDI consists of a package that includes: (a)the inter view booklet, (b) the user manual, 
(c) the training package, (d) a data-entry program and (e) the diagnostic computer program. In 
wave I of the field trials a ‘pre-final’ CIDI version was used (CIDI-Core; World Health 
Organization, 1987). The version allowed the derivation of all DSM-III diagnoses (American 
Psychiatric Association, 1980) listed in Table 1 as well as the derivation of Present State 
Examination (PSE) CATEGO classes (Wing et al, 1974), compatible with selected ICD-9 
diagnostic classes. Only for substance use disorders were the revised criteria according to 
DSM-III-R and ICD-10 taken into account.  
 
The interview consists of 288 symptom questions, not all of which are asked of all 
respondents because of skip rules. Many of the symptom questions have to be asked in 
conjunction with so-called ‘probe’ questions to assess severity and the psychiatric relevance 
of each respondent's answer. Besides symptom questions (a), the CIDI further incorporates 
the following types of questions (Table 2): (b) questions for the assessment of the last and 
first occurrence of a symptom (‘recency’), as well as (c) selected items for duration and 
frequency of selected syndromes.  
 
The version used in the field trials differs from the final CIDI version (World Health 
Organization, 1987b) in the following ways: (a) it does not contain 22 necessary new 
questions to meet ICD-10 criteria as well as DSM-III-R criteria, (b) it contains several items 
adapted from the PSE, (c) unlike to the final CIDI it incorporates additional questions to 
assess the recency of individual symptoms, and (d) an earlier draft of the final alcohol and 
drug section was used (the results for this substance section are reported by Cottler et al 
(following paper, this issue)).  
 
The ES was used to allow judgements about the following areas: (a) the acceptance of the 
CIDI questions by the patient, (b) the overall appropriateness of the CIDI in clinical and 
‘epidemiological’ settings (depending on the site), (c) the length of the interview, and (d) all 
items and sections for which problems were reported by the sites.  
 
The DRS was used to record all observed discrepancies between the interviewer and the 
observer, rating the most likely reasons for the discrepancy.   
 
Translation of the CIDI  
 
Translations of the English version of the CIDI and the other training materials were required 
in Greek, Portuguese Kannada (India), Spanish, Chinese, Norwegian, Dutch, Italian, and 
French; the CIDI had been pilot tested in German. Because of possible cultural and language-
specific problems, all participating centres sent their final translation and back-translation, 
together with a listing of translation problems, to the field trial co-ordinator before the study. 
This allowed for modifications to be made in either the instrument or the manual.  
 
Besides a number of smaller adjustments in some CIDI items, the following problems were 
acknowledged. (a) Parts of the section for organic brain syndrome were difficult to adapt to 
some rural settings and in less developed countries (where there was lesser ability to write or 
draw, and fewer equivalents for sentences and words used) which required modifications 
based on advice from local neurological and neuropsychological research centres. (b) The 
questions for sexual problems as well as symptoms related to pregnancy in unmarried subjects 
were difficult to use in some countries like India. (c) There were difficulties in translating 
some symptom meanings into Chinese and Kannada (e.g. headaches, weakness, indicators for 
trouble in concentrating) (in these cases examples were added in parenthesis to the words in 
the question to clarify the underlying concepts). (d) With regard to the specific probe 
questions, a set of rules was developed for developing countries on how to code certain 
explanations of symptoms by ‘barefoot’ doctors or healers. (e) Because of difficulties 
determining weight and height criteria in some rural sites, interviewer judgement was used to 
assess these criteria.  
 
The translated versions of the CIDI-Core were produced in the same format as the English 
original version, page by page, to avoid mistakes and difficulties in data analysis.   
 
Study procedure and data analysis  
 
The translations and back-translations of the CIDI were finalised by December 1987. In early 
1988 the on-site training courses and the preparation of the study requirements took place. 
Data collection started in February and ended in May 1988.The CIDI interviews were locally 
and centrally edited and checked for mistakes and inconsistencies and were then entered on 
the computer for the final analysis in Munich. Data analysis was completed in July 1988and 
results were circulated to all centres for comment. Final analyses were made in the autumn 
and winter of 1988. For the reliability analyses of the CIDI/DSM-III diagnoses, a modified 
version of the computer program to analyse information collected with the Diagnostic 
Interview Schedule (DIS) Version III was used (Semler et al, 1987).This program allows the 
derivation of the diagnostic categories with and without DSM-III exclusion rules. These were 
not applied in the current analysis. The reliability and acceptability of the substance use 
disorder sections are reported in the following paper.  
 
Results  
 
Of 590 subjects interviewed across all sites and rated by the interviewer and the observer, 575 
were eligible for analysis; 15 were excluded because of violations of the design or incomplete 
codings not allowing the application of the diagnostic computer program. The mean age of 
subjects was 39.3 years (s.d. 14.3), 41.4% were male, 58.6% female, 34.3% were never 
married, 44.9% were married, 9.9% were divorced, 4.7% were separated and 5.7% were 
widowed. Types of setting and numbers of patients at each site are shown in Table 3.  
 
Feasibility and acceptance of the CIDI across centres  
 
The majority of raters in the 18 centres judged the CIDI as being acceptable (49.3% as good, 
41.5% as moderate, 9.2% as poor), with no country-by-country variation. Concerns were 
expressed by only seven interviewers in centres that included in-patients, specifically with 
regard to the rather lengthy section for alcohol and drugs, the format of the depression section 
(being too long and complicated for severely disturbed subjects) and the repetitiveness of 
some probe and recency questions.  
 
The CIDI was also judged as being appropriate for most of the settings, especially out-patient 
and primary-care settings (25.9% as very appropriate, 59.3% as appropriate). It should be 
acknowledged, however, that in clinical settings with more seriously ill subjects, 30.7% of the 
interviewers rated parts of the CIDI as inappropriate. Less favourable ratings were especially 
given for the sections for schizophrenia and depression. At two of the sites interviewing 
almost exclusively acute psychiatric in-patients – the majority of whom had symptoms of 
psychosis (Amsterdam and Milan) – doubts were expressed regarding the validity of some of 
the codings of delusions and hallucinations as well as the assessment of feelings of 
worthlessness and sleep disturbance, and here the CIDI was criticised for relying exclusively 
on the subject's self-report.  
 
One general criticism from many sites concerned the length of the CIDI. Only a few (11.2%) 
of the interviews lasted less than one hour, while 35.4% lasted one to two hours and 36.4% 
lasted two to three hours. In 52 subjects the administration of the CIDI had to be split in two 
sections, in six cases even in three; all of these were conducted in in-patient settings. 
Independent of type of setting or site, the majority rated the CIDI as being too long (65%) or 
even much too long (15%), particularly the sections for depression, alcohol and drugs. The 
centre in India reported that the illiterate respondents took substantially longer than literate 
subjects.  
 
Number of lifetime and six-month diagnoses across centres  
 
Table 4 indicates the number and percentage of subjects fulfilling diagnostic criteria 
according to the CIDI/DSM-III program without the optional DSM-III exclusion rules. 
Diagnoses for alcohol and drug abuse and dependence were not included in this analysis (see 
following paper). A total of 62 subjects did not meet DSM-III criteria for any diagnosis. In 
both the lifetime and six-month time frames, many subjects fulfilled criteria for more than one 
diagnosis. The most frequent lifetime disorders were generalised anxiety (50.3%), major 
depression (31.0%), tobacco use disorders (30.3%), and agoraphobia (30.1%). Lowest 
frequencies were found for eating disorders, pathological gambling and somatisation. There 
was some variability between centres depending on the kind of setting and the severity of the 
patients' conditions. In-patient institutions had the highest mean number of lifetime diagnoses 
per patient (3.2 per patient), followed by out-patient settings (2.6 diagnoses). The lowest 
number of diagnoses were found – as expected – in the general practice settings (1.8) and in 
the health maintenance organisation in St Louis, USA.  
 
Diagnostic agreement  
 
The kappa values across centres were excellent in all diagnostic sections (Table 5). 
Percentage agreements for all diagnoses were above 90%, kappa values were highly 
significant, and with three exceptions above 0.90. Although the CIDI requires complex ratings 
for many of the symptom items - ranging from simple ‘yes/no’ responses, to complex probe 
questions with five different coding options, to judgements of onset and recency of selected 
symptoms and all syndromes - no significant diagnostic disconcordance was found. The 
lowest kappa values were found for somatisation, schizophreniform disorders and anorexia, 
possibly due to low base rates.  
 
Given the base-rate problem with kappa and the relatively small number of subjects per site, it 
is not possible to report separate concordance statistics for each site. Specific intersite 
differences however were examined by analysing the average number of discrepant ratings 
between interviewer and observer. On average 1.68% (s.d. l.64%)of all symptom ratings made 
were discrepant. The number of discrepancies correlated (r= 0.38, P<0.Ol) with the overall 
number of ratings, thus indicating that in-patient settings with multisymptomatic subjects 
revealed slightly higher numbers of discrepancies (2.04) than out-patient (1.52) settings.  
 
Agreement on the item level  
 
The concordance of raters for the symptom questions in all diagnostic sections was good to 
excellent. Figure 1 displays the box-plots of kappa values for symptom questions for each of 
the diagnostic sections. There are only a few items indicating some disagreement among 
raters which deserve closer attention: for example, in the depression section the item “Did you 
tell a doctor about this spell?”; in the schizophrenia section a few questions assessing the 
psychosocial impact of hallucinations and delusions; and for obsessive-compulsive disorders 
the question about had a doctor been told about the syndrome. The section for organic brain 
dysfunction has a wide score distribution because a number of items (drawing, naming 
objects, handling of objects) require close observation of the patient's behaviour, which was 
not possible within our research design, thus causing some disagreements, and because of 
problems arising in translation, as discussed under ‘Method’.  
 
Because the CIDI is specifically designed to assess the occurrence of disorders over the whole 
life-span, the analysis of all time-related questions was of specific interest. For the ‘recency’ 
questions, which are asked in some sections for individual symptoms as well as for 
syndromes, almost perfect agreement was found when dichotomising the rating options into 
‘present in the last four weeks’ and ‘not present in the last four weeks’. The only section with 
a noticeable variation was the one for obsessive-compulsive disorder. This discrepancy may 
be due to the rather lengthy symptom question for obsessive thoughts that was frequently 
readministered by the observer who felt that this question was not asked appropriately by the 
interviewer. In these cases the recency code for the last occurrence of the symptom was 
sometimes different in the interviewers' and observers' codings. Concordance for items for 
which the subjects were asked for the age of first occurrence of a symptom (lifetime) (all 
sections) as well as the frequency of episodes and their length (depression, mania, 
schizophrenia sections) was determined by using the intraclass correlation coefficient (ICC). 
The ICC values revealed excellent concordance, with scores ranging between 0.70 and 0.98.  
 
Discrepancies  
 
The analysis of the DRS revealed an average of almost 4.3 discrepancies (1.68% of all CIDI 
questions) per subject. The highest proportions of discrepancies (number of discrepant 
judgements/number of overall judgements per section) were found in the sections for 
somatisation (33%), phobias (24%), obsessive-compulsive disorder (24%), mood disorders 
(11%), and psychotic disorders (l0%).The most frequent types of disagreement were mistakes 
by an interviewer in either the presentation of the question (23%) or the administration of the 
complicated probe flowchart questions (39%), which need to be followed rigidly. Another 
relatively frequent reason for discrepancies was that the respondent had simply changed 
his/her mind (24%) when the question was readministered by the observer. Implicit problems 
with the formulation of the question (8%) or coding errors (1%) account for only a small 
proportion of the discrepancies.  
 
Because the vast majority (n = 454) of examinations were conducted by pairing a clinical with 
a non-clinical interviewer, it is difficult to study systematically the effect of type of 
interviewer. In comparing, however, the mean number of discrepancies found for clinician 
pairs (n = 77; mean 1.13% discrepancies) with the findings for non-clinician pairs (a = 49; 
mean 1.65010discrepancies) or the clinician-non clinician pairs (mean 1.62% there is an 
indication that the clinician pairs made fewer discrepant decisions. This interpretation must be 
cautious, however, because data from the clinician-clinician comparisons come from three 
non-psychiatric out-patient sites with relatively asymptomatic subjects only, and thus could 
not be regarded as being representative. No differences were found for the comparison of 
‘type of interviewers’ versus ‘type of discrepancies’.  
 
Discussion  
 
Our findings emphasise the generally good acceptance and appropriateness of the CIDI for the 
assessment of symptoms and syndromes of mental disorders and its classification of them 
along the criteria of established diagnostic systems in different settings, countries, and 
cultures. Only few CIDI questions were identified as candidates for modification because of 
national or cultural reasons. The only general criticism referred to the length of the interview. 
Factors mainly responsible for this proved to be the many individual ‘recency’ questions for 
specific symptoms, the sections for somatoform disorders (somatisation, hypochondrias is and 
persistent pain disorder), depressive disorders and, especially, the two new sections for 
alcohol and drug abuse and dependence. The solution to this problem lies in the deletion of 
most symptom recency questions, together with the implementation of summary recency 
questions.  
 
The finding of the good inter-rater reliability of the CIDI in the present study was not 
unexpected because of (a) results of earlier studies in the context of the development of the 
DIS (compare overview by Burke, 1986), (b) previous reliability and validity studies of the 
CIDI (Farmer et al, 1987; Semler et al, 1988; Wittchen et al, 1989; Semler, 1990), and (c) 
subsequent attempts to improve this instrument further. Nevertheless, the fact that 
concordance for almost all diagnoses was above a kappa value of 0.9 needs explanation. 
Regarding test-retest reliability, in a study of the CIDI with two different interviewers 
examining the patient within two to three days, Semler et al (1987) found kappa values that 
are with one exception almost 0.2 kappa values lower than those we report (see Fig. 2). There 
are several explanations for our higher agreement coefficients, all related to our specific 
design characteristics. (a) It might be easier to get better concordance when both raters are in 
the same room. With an observer present, the interviewer might have felt obliged to keep 
more closely than otherwise to the rigid rules for administering the CIDI. (b) The two ratings 
in the inter-rater design were obtained within the same session, thus reducing the possible 
sources of variance occurring because of a change of the patient's psychopathological state. 
Change in the patient's condition might be regarded as an important source of variance in a 
test-retest design with a two- to three-day interval. (c) This study design is of course more 
vulnerable to design violations than a more strict test-retest design with two independent 
investigations. In some cases observers might not have strictly coded the patient response, but 
rather what he/she suspected would be the final coding of the interviewer, thus violating the 
design intent. Although this assumption is difficult to test, it is relatively unlikely that this has 
had a major effect on our data. (d) A more likely explanation might be seen in differences of 
the sample selection. Semler's study was con ducted in severely and acutely disturbed in-
patients, including a relatively high proportion of psychotic patients, whereas the present 
study included many out-patient settings, with some monosymptomatic cases.  
 
The analysis of the reasons for discrepancies demonstrated that the major source of 
discrepancies lies in subtle modifications of the original CIDI question and deviations or 
modifications of the complex set of rules for the probe questions. Complying with the CIDI 
rules seems to be even more important if the instrument is going to be used by such a 
heterogeneous group of users as in our field trials. Although we used clinician and non-
clinician interviewers, we could not demonstrate any important differences between these two 
groups. In this respect it seems important to emphasise that the CIDI requires, for clinician as 
well as non-clinician interviewers, a comprehensive one-week course of structured training 
before its administration.  
 
Thus, we can conclude that the CIDI, as an almost completely standardised diagnostic 
instrument, reduces effectively one major source of disagreement, that is inter-rater variance, 
typically found to be a frequent source of disagreement in all less standardised psychiatric 
interviews. Whether the high inter-rater reliability of the CIDI also results in an improved 
content validity and procedural validity needs to be determined in further studies. Studies of 
this kind are currently under way with a slightly revised and shortened final version of the 
CIDI (World Health Organization, 1989b) in a second wave of the WHO/ADAMHA CIDI 
field trials.    
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